UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of clinical oncology, ISSN 0732-183X, 01/2019, Volume 37, Issue 2, pp. 105 - 114
Letrozole - administration & dosage | Receptors, Estrogen - metabolism | Double-Blind Method | Drug Administration Schedule | Antineoplastic Agents, Hormonal - administration & dosage | Humans | Letrozole - therapeutic use | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Breast Neoplasms - drug therapy | Tamoxifen - administration & dosage | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Letrozole - adverse effects | Tamoxifen - therapeutic use | Postmenopause | Female | Aged | Chemotherapy, Adjuvant | Tamoxifen - adverse effects | Index Medicus | ORIGINAL REPORTS
Journal Article
Aquaculture, ISSN 0044-8486, 12/2020, Volume 529, p. 735656
Journal Article
The lancet oncology, ISSN 1470-2045, 01/2019, Volume 20, Issue 1, pp. 88 - 99
Life Sciences & Biomedicine | Oncology | Science & Technology | Aromatase Inhibitors - administration & dosage | Letrozole - administration & dosage | Multivariate Analysis | Receptors, Estrogen - metabolism | Double-Blind Method | Humans | Letrozole - therapeutic use | Middle Aged | Breast Neoplasms - drug therapy | Receptors, Progesterone - metabolism | Disease-Free Survival | Receptors, Progesterone - analysis | Aromatase Inhibitors - adverse effects | Breast Neoplasms - pathology | Letrozole - adverse effects | Tamoxifen - therapeutic use | Intention to Treat Analysis | Postmenopause | Female | Aged | Chemotherapy, Adjuvant | Aromatase Inhibitors - therapeutic use | Antimitotic agents | Usage | Care and treatment | Analysis | Clinical trials | Breast cancer | Postmenopausal women | Product development | Antineoplastic agents | Health aspects | Cancer | Index Medicus
Journal Article
Future oncology (London, England), ISSN 1479-6694, 11/2019, Volume 15, Issue 32, pp. 3675 - 3682
Life Sciences & Biomedicine | Oncology | Science & Technology | Estradiol - blood | Breast Neoplasms - surgery | Receptors, Estrogen - metabolism | Aromatase Inhibitors - pharmacology | Humans | Letrozole - therapeutic use | Receptor, ErbB-2 - metabolism | Antineoplastic Agents - therapeutic use | Letrozole - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Postmenopause | Female | Neoadjuvant Therapy | Antineoplastic Agents - pharmacology | Aromatase Inhibitors - therapeutic use | Letrozole - administration & dosage | Drug Administration Schedule | Breast Neoplasms - drug therapy | Cross-Over Studies | Androstadienes - administration & dosage | Androstadienes - pharmacology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Androstadienes - therapeutic use | Drug Resistance, Neoplasm - drug effects
Journal Article
Cell chemical biology, ISSN 2451-9456, 03/2018, Volume 25, Issue 3, pp. 291 - 300.e3
drug-exposome interactions | untargeted metabolomics | bioactive food constituents | endocrine-disrupting chemicals | mTOR | metabolic pathway analysis | soy isoflavone | combinatory chemotherapy | Ibrance | CDK4/6 inhibitor | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Metabolomics | Receptors, Estrogen - metabolism | Pyridines - chemistry | Humans | Letrozole - therapeutic use | Phytoestrogens - chemistry | Piperazines - chemistry | Letrozole - pharmacology | MCF-7 Cells | Female | Principal Component Analysis | Phytoestrogens - pharmacology | Pyridines - therapeutic use | Carbon - metabolism | Zearalenone - chemistry | Genistein - chemistry | Piperazines - therapeutic use | Breast Neoplasms - drug therapy | Piperazines - pharmacology | Letrozole - chemistry | Diet | Metabolome - drug effects | Breast Neoplasms - pathology | Genistein - pharmacology | Pyridines - pharmacology | Zearalenone - pharmacology
Journal Article
Psychoneuroendocrinology, ISSN 0306-4530, 08/2019, Volume 106, pp. 111 - 116
Middle-aged females | Estrogens | Doublecortin | Depression | Ki67 | Neurogenesis | Letrozole | Hippocampus | Endocrinology & Metabolism | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Cell Proliferation | Dentate Gyrus - metabolism | Aromatase Inhibitors - pharmacology | Microtubule-Associated Proteins - metabolism | Aromatase - metabolism | Neuropeptides - metabolism | Neural Stem Cells | Hippocampus - drug effects | Letrozole - pharmacology | Depression - drug therapy | Hippocampus - metabolism | Animals | Behavior, Animal - drug effects | Female | Mice | Neurogenesis - drug effects | Neurons - metabolism | Estrogens - metabolism | Letrozole - metabolism | Index Medicus
Journal Article
International journal of gynecology and obstetrics, ISSN 0020-7292, 11/2020, Volume 151, Issue 2, pp. 214 - 218
Pregnancy | Misoprostol | Letrozole | Missed abortion | Medical abortion | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Letrozole - administration & dosage | Double-Blind Method | Abortion, Missed - drug therapy | Humans | Letrozole - therapeutic use | Misoprostol - administration & dosage | Administration, Intravaginal | Treatment Outcome | Abortifacient Agents, Nonsteroidal - therapeutic use | Pregnancy Trimester, First | Young Adult | Iran | Abortifacient Agents, Nonsteroidal - administration & dosage | Adult | Female | Drug Therapy, Combination | Misoprostol - therapeutic use | Prenatal Care | Index Medicus
Journal Article
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, ISSN 1570-0232, 01/2021, Volume 1162, pp. 122495 - 122495
Journal Article
International journal of cancer, ISSN 0020-7136, 10/2019, Volume 145, Issue 8, pp. 2114 - 2121
letrozole | breast cancer | arthralgia/joint pain | myalgia/muscle and limb pain | endocrine treatment/therapy | aromatase inhibitor | Life Sciences & Biomedicine | Oncology | Science & Technology | Postmenopause - drug effects | Humans | Letrozole - therapeutic use | Middle Aged | Arthralgia - physiopathology | Arthralgia - chemically induced | Breast Neoplasms - drug therapy | Breast Neoplasms - physiopathology | Musculoskeletal Pain - chemically induced | Aromatase Inhibitors - adverse effects | Pain Measurement - methods | Time Factors | Letrozole - adverse effects | Female | Musculoskeletal Pain - physiopathology | Aged | Aromatase Inhibitors - therapeutic use | Postmenopause - physiology | Antimitotic agents | Cancer patients | Care and treatment | Breast cancer | Drug therapy | Antineoplastic agents | Cancer | Therapy | Pain | Statistical analysis | Aromatase | Joints (anatomy) | Muscles | Median (statistics) | Statistical tests | Index Medicus
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 12/2017, pp. 1 - 8
Journal Article
Annals of oncology, ISSN 0923-7534, 04/2018, Volume 29, Issue 4, pp. 888 - 894
Health-related quality of life | Metastatic breast cancer | ER+/HER2 | Letrozole | Palbociclib | Life Sciences & Biomedicine | Oncology | Science & Technology | Piperazines - administration & dosage | Letrozole - administration & dosage | Pyridines - administration & dosage | Double-Blind Method | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Breast Neoplasms - drug therapy | Breast Neoplasms - physiopathology | Breast Neoplasms - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Placebos | Postmenopause | Quality of Life | Female | Index Medicus | letrozole | metastatic breast cancer | health-related quality of life | HER2 | Original | palbociclib | ER
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 11/2018, Volume 172, Issue 2, pp. 371 - 379
CYP2A6 | Breast cancer | Arthralgia | Letrozole | Pharmacogenomics | Life Sciences & Biomedicine | Oncology | Science & Technology | Aromatase Inhibitors - administration & dosage | Letrozole - administration & dosage | Cytochrome P-450 CYP2A6 - genetics | Antineoplastic Agents, Hormonal - administration & dosage | Humans | Middle Aged | Genotype | Arthralgia - physiopathology | Breast Neoplasms - drug therapy | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Letrozole - blood | Aged, 80 and over | Breast Neoplasms - blood | Adult | Female | Aged | Arthralgia - genetics | Women | Care and treatment | Cancer patients | Adjuvant treatment | Cytochrome P-450 | Genetic aspects | Postmenopausal women | Health aspects | Cancer | Index Medicus
Journal Article
Zanco journal of medical sciences, ISSN 1995-5588, 07/2020, Volume 24, Issue 1, pp. 21 - 27
Journal Article